Reuters World News  cover image

Trump critic cases dropped, Novo Nordisk and Obamacare

Reuters World News

00:00

Novo Nordisk Alzheimer's Trial Fails

Julie Steenhuysen reports Novo Nordisk's semaglutide trial didn't slow Alzheimer's progression, though prevention studies are still hoped for.

Play episode from 03:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app